Treatment for Advanced B-Cell Lymphoma

NCT01859819 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large Cell Lymphoma
Burkitt's Lymphoma
High Grade B-cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: IT Cytarabine

Sponsor

New York Medical College